GlassScriptPhysician profile
Eran S Zacks
NPI 1982760526
$26,828.95
in general payments reported to CMS, 2019-2025
26 companies · $12K in 2025
The $12K reported for 2025 was more than what 83% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,281 · 2020: $336 · 2021: $4,703 · 2022: $4,385 · 2023: $852 · 2024: $664 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $10K · Food and Beverage: $3,123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,000.00 |
| Food and Beverage | $3,123.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $10,941.51 | 2019-2025 | Watchman, Watchman Access System, Watchman Flx |
| Abbott Laboratories | $8,554.16 | 2019-2025 | Jot Dx, Gallant, Aveir |
| Biosense Webster, INC. | $2,845.50 | 2019-2022 | |
| Medical Device Business Services, INC. | $2,437.50 | 2022 | |
| Biotronik INC. | $451.81 | 2023-2025 | Acticor 7 Vr-T Dx, Amvia Edge |
| Medtronic, INC. | $396.43 | 2021-2025 | Aurora Ev-Icd Mri Surescan, Micra, Azure Xt Dr Mri Surescan |
| Pfizer INC. | $198.10 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $155.22 | 2023-2025 | |
| Sanofi-Aventis U.S. LLC | $145.64 | 2019-2023 | |
| Alnylam Pharmaceuticals INC. | $105.39 | 2025 | Onpattro, Amvuttra |
| Medtronic Vascular, INC. | $98.28 | 2019 | |
| Merck Sharp & Dohme LLC | $77.46 | 2024-2025 | Verquvo |
| Cardiva Medical, INC. | $69.48 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Cvrx, INC. | $56.41 | 2024-2025 | Barostim Neo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $51.64 | 2019-2025 | Lifevest |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $38.79 | 2019-2024 | Xarelto |
| Esperion Therapeutics, INC. | $30.04 | 2025 | Nexletol |
| Amgen INC. | $27.56 | 2019 | |
| Novo Nordisk INC | $25.10 | 2025 | Wegovy |
| Astrazeneca Pharmaceuticals LP | $21.33 | 2025 | Lokelma |
| Coloplast Corp | $19.40 | 2019 | |
| Bridgebio Pharma, INC. | $18.37 | 2025 | Attruby |
| Altathera Pharmaceuticals LLC | $18.02 | 2025 | Sotalol Hydrochloride |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.21 | 2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $14.91 | 2023 | Camzyos |
| Amarin Pharma, INC. | $14.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eran Zacks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.